Cite
MLA Citation
David J. Pinato et al.. “Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy.” Journal of immunotherapy, vol. 43, no. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100133184886.0x000013